AT3 Administration During ECLS (EP Video)
Jordan Voss discusses antithrombin 3 (AT3) administration during ECLS cases (15:30 minutes).
World's Largest Resource for Cardiovascular Perfusion
Jordan Voss discusses antithrombin 3 (AT3) administration during ECLS cases (15:30 minutes).
Two hundred patients who were scheduled to undergo valve repair and/or replacement surgery with or without coronary surgery were enrolled in the study. The patients were randomized to undergo CPB with either the Avecor oxygenator with Trillium™ (Medtronic, Minneapolis, MN, USA), a biopassive surface, or the Monolyth (Sorin, Irvine, CA, USA) oxygenator without coating.
Dr. Jeffrey Darst discusses percutaneous VV ECMO from a cardiologist's perspective (28:12 minutes).